Theratechnologies Inc
TSX:TH
Theratechnologies Inc
TSX:TH
Price:
1.75 CAD
-1.13%
Market Closed
Updated:
May 29, 2024
Theratechnologies Inc
Additional Paid In Capital
|
Theratechnologies Inc
Additional Paid In Capital Peer Comparison
Comparables:
ZYME
RPTX
FUSN
AUPH
EDT
Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Theratechnologies Inc
TSX:TH
|
Additional Paid In Capital
$23.9m
|
CAGR 3-Years
24%
|
CAGR 5-Years
22%
|
CAGR 10-Years
12%
|
|
|
Zymeworks Inc
NYSE:ZYME
|
Additional Paid In Capital
$142.3m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
63%
|
CAGR 10-Years
N/A
|
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Additional Paid In Capital
$61.8m
|
CAGR 3-Years
119%
|
CAGR 5-Years
190%
|
CAGR 10-Years
N/A
|
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Additional Paid In Capital
$599m
|
CAGR 3-Years
14%
|
CAGR 5-Years
286%
|
CAGR 10-Years
N/A
|
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Additional Paid In Capital
$105.4m
|
CAGR 3-Years
34%
|
CAGR 5-Years
33%
|
CAGR 10-Years
25%
|
|
|
Spectral Medical Inc
TSX:EDT
|
Additional Paid In Capital
CA$8.9m
|
CAGR 3-Years
4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
9%
|
See Also
What is Theratechnologies Inc's Additional Paid In Capital?
Additional Paid In Capital
23.9m
USD
23.9m
USD
Based on the financial report for Feb 29, 2024, Theratechnologies Inc's Additional Paid In Capital amounts to 23.9m USD.
What is Theratechnologies Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
12%
12%
Over the last year, the Additional Paid In Capital growth was 23%. The average annual Additional Paid In Capital growth rates for Theratechnologies Inc have been 24% over the past three years , 22% over the past five years , and 12% over the past ten years .
You don't have any saved screeners yet
